Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03618251
Other study ID # FCD_2017_20
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 15, 2018
Est. completion date December 4, 2020

Study information

Verified date September 2021
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Stroke is a common disease. It is increasingly managed in non-specialized centers. The volume of the lesion, evaluated on the diffusion weighted imaging, is a prognostic factor of clinical progression and is useful for the treatment decision. There is therefore a real interest in having a reliable software able to detect the stroke and evaluate the volume of the cerebral infarction. The aim is to provide rapid information to the interventional neuroradiologist and optimize the care of the patient. The Alberta Stroke Program Early Computed Tomography Score currently used to predict response to treatment divides the territory of the middle cerebral artery. It has a few limitations, it is unreproducible and concerns only the territory of the middle cerebral artery. Manual volumetry is a long and also not very reproducible technique. The aim of our study is to evaluate the reproducibility and diagnostic performances of the automated segmentation software based on the diffusion weighted imaging sequence, and to compare it to manual and semi-automatic measurements.


Recruitment information / eligibility

Status Completed
Enrollment 406
Est. completion date December 4, 2020
Est. primary completion date September 4, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients admitted for a recent neurological deficit (less than 24 hours), suspected for a stroke. Non inclusion criteria : - Pregnant or breastfeeding women - Patients with absolute contraindications to MRI

Study Design


Related Conditions & MeSH terms

  • Stroke
  • Stroke, Software Verification, Diffusion Weighted MRI, Neuroimaging

Intervention

Diagnostic Test:
specific MRI sequences
MRI with B 2000 of diffusion weighted imaging and the coefficient of apparent diffusion

Locations

Country Name City State
France Fondation A De Rothschild Paris

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Automated volume assessment of acute stroke Our objective is to compare several volumetric techniques (manual, semi-manual, automatic) based on the B 2000 of diffusion weighted imaging and the coefficient of apparent diffusion.
We will also evaluate the correlation between the volumes obtained by the different techniques and the final volume of FLAIR infarction and diffusion in a subgroup of patients for whom a follow-up MRI is feasible.
1 hour